Our Pricing

Compare Mounjaro Tablets With Other Weight Treatments

When comparing mounjaro vs wegovy vs saxenda uk options, understanding the differences in mechanism, efficacy, and dosing schedules is essential for making an informed choice. At Cured Pharmacy, our UK-registered clinical team provides transparent pricing and expert guidance on all licensed weight loss treatments, helping you find the right medication for your individual needs. All prescription treatments require assessment by a UK prescriber before dispensing.

How Mounjaro Differs From Other Weight Loss Treatments

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments such as Wegovy and Saxenda, which activate only GLP-1 receptors, tirzepatide simultaneously targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual mechanism produces enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

In the SURPASS-3 clinical trial, participants receiving the 15mg maintenance dose of tirzepatide achieved an average body weight reduction of 22.5% over 72 weeks, compared to baseline [1]. This represents substantially greater weight loss than that observed with semaglutide-based treatments in comparable trial populations. The dual-agonist mechanism appears to offer additive metabolic benefits beyond what single-pathway medications can achieve.

At Cured Pharmacy, Mounjaro is available from £135.00, subject to clinical assessment by a UK prescriber. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures all weight loss treatments meet stringent UK licensing and safety standards before dispensing.

Mounjaro vs Wegovy: Comparing Tirzepatide and Semaglutide

Wegovy (semaglutide) is administered as a once-weekly subcutaneous injection, identical in frequency to Mounjaro. Both medications require dose escalation over several weeks to minimise gastrointestinal side effects such as nausea and diarrhoea. The starting dose for Wegovy is 0.25mg weekly, gradually increasing to a maintenance dose of 2.4mg. Mounjaro begins at 2.5mg weekly, with potential escalation to 5mg, 10mg, or 15mg depending on response and tolerability.

At Cured Pharmacy, Wegovy is available with transparent upfront pricing, and all prescriptions are issued following a free clinical consultation with a UK-registered prescriber. Both Mounjaro and Wegovy are prescription-only medications that cannot be dispensed without proper medical assessment.

Efficacy and Clinical Trial Data

Head-to-head comparisons show tirzepatide consistently produces greater weight reduction than semaglutide across multiple doses. In the SURPASS-2 trial, participants on tirzepatide 15mg lost an average of 12.4kg more than those on semaglutide 1mg over 40 weeks [2]. The STEP trials, which evaluated semaglutide for weight management, reported average weight loss of 14.9% with the 2.4mg dose over 68 weeks [3].

Both medications work by enhancing satiety, slowing gastric emptying, and improving glycaemic control, but tirzepatide's dual-receptor activation appears to amplify these effects. UK prescribers typically consider individual patient factors, including BMI, comorbidities, injection frequency preference, and cost when recommending between these treatments.

Saxenda: Daily Injectable Liraglutide for Weight Management

Saxenda may be considered for patients who have previously used liraglutide-based treatments, those who prefer daily dosing control, or individuals seeking a lower-cost entry point into GLP-1 therapy. UK prescribers assess each patient's medical history, weight loss goals, and lifestyle factors when determining the most appropriate medication.

At Cured Pharmacy, Saxenda is available with full clinical support from our UK-registered team. All weight loss injections require proper training on administration technique, which our pharmacists provide as part of the dispensing service.

How Saxenda Compares to Weekly Injections

Saxenda contains liraglutide, an earlier-generation GLP-1 receptor agonist that requires daily subcutaneous injection rather than weekly dosing. While clinical trials demonstrated average weight loss of 8% over 56 weeks with liraglutide 3mg daily, this is notably lower than the results achieved with tirzepatide or higher-dose semaglutide [4].

The daily injection schedule may be less convenient for some patients, though others prefer the flexibility of adjusting doses more frequently. Saxenda is typically initiated at 0.6mg daily and increased by 0.6mg increments each week until reaching the maintenance dose of 3mg. Common side effects include nausea, diarrhoea, constipation, and headache, similar to other GLP-1 medications.

Oral Weight Loss Treatments: Orlistat and Wegovy Tablets

Cured Pharmacy stocks multiple orlistat formulations, including branded Xenical, generic orlistat capsules, Alli, and Orlos. Prescription-strength 120mg capsules require clinical assessment, while 60mg formulations may be available for purchase following a pharmacy consultation. Patients are advised to follow a reduced-fat diet (less than 30% of calories from fat) to minimise side effects.

Wegovy Oral Tablets represent a new formulation of semaglutide in pill form, currently available for pre-order at Cured Pharmacy. This offers an injectable-free option for patients seeking GLP-1 therapy benefits without needles. The oral formulation requires specific administration instructions (taken on an empty stomach with minimal water) to ensure adequate absorption.

Orlistat: Fat Absorption Inhibitor

Orlistat works through a completely different mechanism than GLP-1 medications. It inhibits pancreatic and gastric lipases, enzymes responsible for breaking down dietary fats, thereby reducing fat absorption by approximately 30% [5]. Unabsorbed fat is excreted in stools, which can cause gastrointestinal side effects including oily spotting, flatulence, and urgent bowel movements, particularly when consuming high-fat meals.

Clinical trials show orlistat produces average weight loss of 3-5% over one year when combined with a reduced-calorie diet [5]. This is considerably less than GLP-1 receptor agonists, but orlistat remains a suitable option for patients who cannot tolerate injections or have contraindications to GLP-1 therapy. Both prescription-strength (120mg) and lower-dose over-the-counter formulations (60mg) are available in the UK.

Which Weight Loss Treatment Is Right for You?

At Cured Pharmacy, our free online consultation takes under three minutes and is reviewed by UK-registered prescribers who specialise in weight management. We provide transparent pricing before you begin the assessment, ensuring you understand the full cost of treatment. All medications are genuine UK-licensed products dispensed by our GPhC-registered pharmacy (9012511).

Treatment choice should be individualised based on your specific circumstances. Some patients achieve excellent results with daily Saxenda injections, while others prefer the convenience and enhanced efficacy of weekly Mounjaro or Wegovy. Those unable to tolerate injections may find orlistat-based treatments more suitable, despite lower average weight loss outcomes.

Factors UK Prescribers Consider

Your UK prescriber will evaluate multiple clinical and lifestyle factors when recommending a weight loss medication. These include your current BMI, presence of weight-related comorbidities (such as type 2 diabetes, hypertension, or sleep apnoea), previous weight loss attempts, medication tolerability, injection preference, and budget considerations.

NICE guidelines recommend considering pharmacological treatment for weight management in adults with a BMI of 30 kg/m² or greater, or 28 kg/m² or greater with weight-related comorbidities. GLP-1 receptor agonists are typically reserved for patients with higher BMIs or those who have not achieved adequate results with lifestyle modifications and other interventions.

Starting Your Weight Loss Treatment at Cured Pharmacy

Beginning treatment at Cured Pharmacy is straightforward and fully remote. Complete our online clinical questionnaire, which asks about your medical history, current medications, weight loss goals, and any contraindications. A UK-registered prescriber reviews your assessment, typically within hours, and determines the most appropriate treatment based on clinical guidelines and your individual needs.

If approved, your prescription is sent directly to our dispensing team. We offer discreet packaging and reliable delivery across the UK, with tracking provided for all orders. Our pharmacists are available by phone ((+44) 116 4646009) to answer questions about administration technique, side effect management, and dose escalation schedules.

All GLP-1 medications require gradual dose escalation to minimise gastrointestinal side effects. Your prescriber will provide a specific titration schedule, and follow-up consultations ensure your treatment remains safe and effective. Weight loss medications work best when combined with dietary modifications and increased physical activity, and our clinical team can provide guidance on evidence-based lifestyle changes to optimise your results.

Cured Pharmacy guarantees the lowest prices in the UK for weight loss treatments, with transparent upfront costs and no hidden fees. Our commitment to accessibility means you can access the same medications available through traditional healthcare channels, with the convenience of online assessment and home delivery.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
4. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892
5. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals, and no medication guarantees specific outcomes.